In this study, we found that HIF-PH encoded by EGLN1 is a potential therapeutic target for chronic lymphocytic leukemia and its inhibitor, molidustat, has considerable killing effect on CLL cell lines. The gene discussed is EGLN1; the disease is B-cell chronic lymphocytic leukemia.